Young Investigator Awards for outstanding publications 2020

The winners of the annual Young Investigator Awards for outstanding publications during 2020  Basic Science Award Article: A dual apolipoprotein C-II mimetic – apolipoprotein C-III antagonist peptide lowers plasma triglycerides.  Published in: Science Translational Medicine, Sci Transl Med 2020, 12(528): eaaw7905. DOI: 10.1126/scitranslmed.aaw7905 Author: Anna WolskaAnna Wolska is a researcher in projects related to new methods for estimation of […]
Share this:

Continue reading


Keynote Lecture

Professor Chris Packard: Triglyceride metabolism and its clinical implications Chris Packard is the R&D Director of NHS Greater Glasgow & Clyde, Scotland. He holds an Honorary Professorship of Vascular Biochemistry at the University of Glasgow, and is a Consultant Clinical Scientist for NHS Greater Glasgow & Clyde Biochemistry. Over his career, Professor Packard has focussed […]
Share this:

Continue reading


Plenary 3. Wed 02 June – talk 3, DeLisa Fairweather

Gender and Cardiovascular Disease: DeLisa Fairweather, Baltimore, USA The rise of cardiometabolic disease as global health threat: towards the UN 2030 goals DeLisa Fairweather, PhD, is an Associate Professor of Medicine, Immunology and Clinical Translational Science at Mayo Clinic in Jacksonville, Florida and Director of Translational Research in the Department of Cardiovascular Medicine. Her research […]
Share this:

Continue reading


Plenary 3. Wed 02 June – talk 2, Miguel Martinez-Gonzalez

The Mediterranean diet, its components, and cardiovascular disease: Miguel Martinez-Gonzalez, Pamplona, Spain The rise of cardiometabolic disease as global health threat: towards the UN 2030 goals Miguel Martinez-Gonzalez is a chronic disease epidemiologist and the leader of several cohorts and trials conducted in Spain. His major research interests include the effects of the Mediterranean food […]
Share this:

Continue reading


Plenary 3. Wed 02 June – Talk 1, Juleen R. Zierath

Exercise, inactivity, and circadian rhythms – re-setting the clock in metabolic disease: Juleen Zierath, Stockholm, Sweden The rise of cardiometabolic disease as global health threat: towards the UN 2030 goals Juleen R. Zierath is Professor of Experimental Physiology and leads the Section of Integrative Physiology, Department of Molecular Medicine and Surgery at Karolinska Institutet, Stockholm, […]
Share this:

Continue reading


Plenary 2. Tues 01 June – talk 3, Jean-Charles Fruchart

SPPARM alpha agonist for Nutrient and Energy Metabolism – Mechanisms and Therapeutic Opportunities: Jean-Charles Fruchart, Lille/Basel, France Future CVD management: from gene to phenotype to treatment Jean-Charles Fruchart is currently Professor at the Pasteur Institute, Lille, France, President of the Residual Risk Reduction Initiative (R3i) Foundation, and a member of the International Atherosclerosis Society board. […]
Share this:

Continue reading


Plenary 2. Tues 01 June – talk 2, Charalambos Antoniades

Atherosclerosis affecting fat: What can we learn by imaging perivascular adipose tissue? Charalambos Antoniades, Oxford, UK Future CVD management: from gene to phenotype to treatment Charalambos (Charis) Antoniades is a full Professor of Cardiovascular Medicine and Head of Acute Vascular Imaging Centre of the University of Oxford, the Deputy Head of the Division of Cardiovascular […]
Share this:

Continue reading


Plenary 2. Tues 01 June – talk 1, Mark Daly

From genetic discovery to clinical interventions to combat atherosclerosis: Mark Daly, Helsinki, Finland Future CVD management: from gene to phenotype to treatment Mark Daly is Director of the Institute for Molecular Medicine Finland (FIMM) since February 2018, in addition to affiliations with Harvard Medical School, Massachusetts General Hospital and the Broad Institute, and co-director of […]
Share this:

Continue reading


Plenary 1. Mon 31 May – talk 4, Renu Virmani

Coronary artery calcification and its progression: what does it really mean? Renu Virmani, Baltimore, USA Atherosclerosis: metabolism dysfunction drives inflammation in the vessels Renu Virmani is President of CVPath Institute, Gaithersburg, and Clinical Professor, Department of Pathology at Georgetown University; University of Maryland-Baltimore; George Washington University, and Vanderbilt University, USA. MD. She is recognized as […]
Share this:

Continue reading